US 10398778
Method for enhancing specific immunotherapies in cancer treatment
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 10398778 (Method for enhancing specific immunotherapies in cancer treatment) held by Providence Health & Services—Oregon expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Providence Health & Services—Oregon
- Grant date
- Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61K47/26, A61K9/0019